← Back to Conditions

Hypereosinophilic syndrome

disorder
SNOMED 393573009CUI C1540912

Overview

Hypereosinophilic syndrome is a disorder.

Auto-generated from clinical reference data. Not a substitute for medical advice.

Research Evidence

Peer-reviewed studies linked via MeSH term "Syndrome, Hypereosinophilic" from the MEDLINE/PubMed database.

Sort:
Parasitic-induced Loeffler's syndrome: A systematic review based on clinical reports.
[object Object], [object Object], [object Object] et al. · J Infect Public Health · 2026
PMID: 41161022Meta-Analysis
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis.
[object Object], [object Object], [object Object] et al. · Allergy Asthma Proc · 2025
PMID: 40011991Meta-Analysis
Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review.
[object Object], [object Object], [object Object] et al. · Rhinology · 2025
PMID: 40305840Meta-Analysis
What we have learned about lymphocytic variant hypereosinophilic syndrome: A systematic literature review.
[object Object], [object Object] · Clin Immunol · 2022
PMID: 35307610Meta-Analysis
Mepolizumab in Hypereosinophilic Syndrome: A Systematic Review and Meta-analysis.
[object Object], [object Object], [object Object] et al. · Clinics (Sao Paulo) · 2021
PMID: 34644737Meta-AnalysisFull text (PMC)
Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis.
[object Object], [object Object], [object Object] · Br J Haematol · 2021
PMID: 34105142Meta-Analysis
Endomyocardiofibrosis: A Systematic Review.
[object Object], [object Object], [object Object] et al. · Curr Probl Cardiol · 2021
PMID: 33418479Meta-Analysis
Gleich syndrome: a systematic review.
[object Object], [object Object], [object Object] et al. · Int J Dermatol · 2020
PMID: 32557651Meta-Analysis
Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome.
[object Object], [object Object], [object Object] et al. · Front Immunol · 2022
PMID: 36091012RCTFull text (PMC)
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome.
[object Object], [object Object], [object Object] et al. · Front Immunol · 2022
PMID: 35493455RCTFull text (PMC)

Quick Facts

SNOMED CT
393573009
UMLS CUI
C1540912
Fully Specified Name
Hypereosinophilic syndrome (disorder)
Specialists
0
Diagnostic Biomarkers
0
Known Treatments
9
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.